---
document_datetime: 2025-12-18 15:38:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/puregon-epar-all-authorised-presentations_en.pdf
document_name: puregon-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8305621
conversion_datetime: 2025-12-25 08:26:04.37203
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invente d) name   | Strength       | Pharmaceutical form    | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size                                |
|------------------|--------------------|----------------|------------------------|---------------------------|-----------------------|---------------------------|------------------------------------------|
| EU/1/96/008/038  | Puregon            | 300 IU/0.36 mL | Solution for injection | Subcutaneous use          | cartridge (glass)     | 0.480 mL (833 IU/mL)      | 1 cartridge + 2 packs with 3 pen needles |
| EU/1/96/008/039  | Puregon            | 600 IU/0.72 mL | Solution for injection | Subcutaneous use          | cartridge (glass)     | 0.840 mL (833 IU/mL)      | 1 cartridge + 2 packs with 3 pen needles |
| EU/1/96/008/041  | Puregon            | 900 IU/1.08 mL | Solution for injection | Subcutaneous use          | cartridge (glass)     | 1.230 mL (833 IU/mL)      | 1 cartridge + 3 packs with 3 pen needles |